Nahdi Medical Management
Management criteria checks 3/4
Nahdi Medical's CEO is Yasser Ghulam Abdulaziz Joharji, appointed in Sep 2014, has a tenure of 10.25 years. directly owns 0.054% of the company’s shares, worth SAR8.12M. The average tenure of the management team and the board of directors is 7.7 years and 3.2 years respectively.
Key information
Yasser Ghulam Abdulaziz Joharji
Chief executive officer
ر.س500.0k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.3yrs |
| CEO ownership | 0.05% |
| Management average tenure | 7.7yrs |
| Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Nahdi Medical (TADAWUL:4164)
Oct 18
Nahdi Medical Company's (TADAWUL:4164) Share Price Is Matching Sentiment Around Its Earnings
Sep 13Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next
Aug 07Nahdi Medical (TADAWUL:4164) Has Announced A Dividend Of SAR2.50
Aug 03Capital Allocation Trends At Nahdi Medical (TADAWUL:4164) Aren't Ideal
Jun 18There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings
Apr 25Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence
Jan 07Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report
Aug 07Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jul 25Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Mar 22Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings
Dec 13We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve
Aug 20Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?
Aug 01CEO
Yasser Ghulam Abdulaziz Joharji (53 yo)
10.3yrs
Tenure
ر.س500,000
Compensation
Mr. Yasser Ghulam Bin Abdulaziz Joharji serves as Chief Executive Officer at Nahdi Medical Company since September 1, 2014 and serves as its Executive Non-Independent Director since October 04, 2021. He se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Non-Independent Director | 10.3yrs | ر.س500.00k | 0.054% SAR 8.1m | |
| Chief Financial Officer | 8.9yrs | no data | 0.0077% SAR 1.2m | |
| Chief Operation Officer | no data | no data | no data | |
| Legal Senior Department Manager & Head of the Legal Department | 4.3yrs | no data | no data | |
| Chief Commercial & Marketing Officer | no data | no data | no data | |
| Chief Human Resources Officer | 6.4yrs | no data | no data | |
| Chief Network Development Officer | 8.9yrs | no data | no data | |
| Chief Corporate Governance & Business Support Officer | 11yrs | no data | no data | |
| Chief Information Technology Officer | 5.9yrs | no data | no data | |
| Chief Omni-health Officer | no data | no data | no data | |
| Chief Supply Chain Officer | no data | no data | no data | |
| Chief Omnihealth Officer | less than a year | no data | no data |
7.7yrs
Average Tenure
50yo
Average Age
Experienced Management: 4164's management team is seasoned and experienced (7.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Non-Independent Director | 3.2yrs | ر.س500.00k | 0.054% SAR 8.1m | |
| Chairman of the Board | 3.2yrs | ر.س500.00k | no data | |
| Non-Executive Independent Director | 3.2yrs | ر.س710.00k | no data | |
| Non-Executive Independent Director | 3.2yrs | ر.س605.00k | no data | |
| Vice Chairman of the Board | 3.2yrs | ر.س500.00k | no data | |
| Non-Executive Non-Independent Director | 3.2yrs | ر.س500.00k | no data | |
| Non-Executive Independent Director | 3.2yrs | ر.س630.00k | no data |
3.2yrs
Average Tenure
53yo
Average Age
Experienced Board: 4164's board of directors are considered experienced (3.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 23:30 |
| End of Day Share Price | 2024/12/22 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nahdi Medical Company is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Duaa AlFadda | BofA Global Research |
| Michel Salameh | Citigroup Inc |
| Ahmed Moataz | EFG-Hermes Research |